Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
08/2002
08/14/2002EP1230253A1 Combinatorial library synthesis and pharmaceutically active compounds produced thereby
08/14/2002EP0806964B1 Chemical compounds
08/14/2002DE10104250A1 Markierungsfähige Verbindungen zur einfachen Synthese von 3'-[18F]Fluor-3'-deoxythymidin und Verfahren zu deren Herstellung Marker compounds capable for easy synthesis of 3 '- [18F] fluoro-3'-deoxythymidine and processes for their preparation
08/14/2002CN1364170A Thiophene A2A receptor agaonists
08/14/2002CN1089086C Luminide and macroluminide class of pharmaceuticals
08/13/2002US6434248 Soft hearing aid moulding apparatus
08/13/2002US6432924 Anticancer agents; rheumatic diseases; viricides
08/13/2002US6432637 Method for determining a base sequence of a nucleotide strand
08/13/2002US6432247 Method of manufacturing a soft hearing aid
08/13/2002CA2269947C Covalent polar lipid conjugates for targeting
08/08/2002WO2002060913A1 Labelling compounds for the simple synthesis of 3'(18f)fluoro-3'-deoxy thymidine and a method for the production thereof
08/08/2002WO2002060454A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
08/08/2002WO2001096357A3 Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
08/08/2002US20020107237 Topoisomerase inhibitors
08/08/2002US20020107221 Nucleosides with anti-hepatitis B virus activity
08/08/2002US20020106652 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
08/08/2002US20020106363 For therapy and diagnosis of malignant neoplasias
08/08/2002DE10105079A1 Fotolabile Schutzgruppen für die Synthese von Biopolymeren Photolabile protecting groups for the synthesis of biopolymers
08/08/2002DE10105077A1 Hybrid-Schutzgruppe Hybrid-protecting group
08/08/2002CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
08/07/2002EP1229040A2 Nucleoside monophosphate derivative, a processor for their production and their use as immunosuppressive drugs
08/07/2002EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells
08/06/2002US6429315 Process for preparing N6-substituted adenosine derivatives
08/06/2002US6429275 Functionalized silicon compounds and methods for their synthesis and use
08/06/2002CA2076060C Compounds named the adenophostins, their preparation and their therapeutic use
08/01/2002WO2002059084A2 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
08/01/2002WO2002058740A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
08/01/2002WO2002036832A3 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
08/01/2002US20020103367 Purine nucleosides or purine nucleotides modified at the 2-, 6- or 8-position of the purine ring prepared by reacting a purine starting material containing a leaving group attached to the 2,6,8 positon with functionalized alkene
08/01/2002US20020103158 Dinucleoside polyphosphates which facilitate secretory mechanisms, i.e. increasing the hydration of mucus secretions, stimulating the production of mucins and increasing ciliary beat frequency to facilitate clearance
08/01/2002US20020103157 Stimulation of tear secretion by administering uridine 5'-triphosphate dinucleotides, cytidine 5'-triphosphate, adenosine 5'-triphosphate or their useful analogs; enhances mucociliary clearance of nasolacrimal duct
08/01/2002US20020102590 Fluorescent nucleobase conjugates having anionic linkers
08/01/2002US20020102586 Massive parallel method for decoding DNA and RNA
08/01/2002US20020102567 Method for comparing nucleic acid sequences
07/2002
07/31/2002EP1227103A2 Ring-expanded nucleosides and nucleotides
07/31/2002EP1226148A2 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
07/31/2002EP1225877A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
07/31/2002EP1102783A4 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom
07/31/2002EP0980377B1 Anti-viral pyrimidine nucleoside analogues
07/30/2002US6426408 Plurality of nucleotide units with linking group
07/30/2002US6426337 Antiinflammatory agents
07/30/2002CA2119351C Phosphoramidate analogs of 5-fluoro-2'-deoxyuridine
07/30/2002CA2079777C Oligonucleotide analogs
07/25/2002WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/25/2002WO2002057288A1 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
07/25/2002WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/25/2002US20020099202 Compoound for use in the sequencing of nucleic acids
07/25/2002US20020099182 Purification of oligomers
07/25/2002US20020099030 Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties
07/25/2002US20020098231 Antisense nucleotides; drug delivery; anticancer agents; gene expression inhibition
07/24/2002EP1224280A2 Design of high affinity rnase h recruiting oligonucleotide
07/24/2002EP1224203A2 Antisense modulation of protein kinase c-theta expression
07/24/2002EP1224198A1 Nucleoside derivatives with photolabile protecting groups
07/24/2002EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression
07/24/2002EP0850248B1 Compositions and methods for the synthesis of organophosphorus derivatives
07/24/2002CN1088068C Ascomycins
07/23/2002US6423852 Process for the preparation of trifluorothymidine derivatives
07/23/2002US6423694 Method of treating otitis media with uridine triphosphates and related compounds
07/18/2002WO2002029003A3 Massive parallel method for decoding dna and rna
07/18/2002WO2002021098B1 A method for identifying polymorphisms
07/18/2002US20020095044 Substituted isoindolinone derivatives
07/18/2002US20020095033 Monocyclic L-nucleosides, analogs and uses thereof
07/18/2002US20020094963 Benzimidazole derivatives
07/17/2002EP1223173A2 Novel 2'-O-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
07/17/2002EP0817637B1 Synergistic combinations of zidovudine, 1592u89 and 3tc
07/16/2002US6420169 Device for generating preferential nucleotide sequences; for use as tools drug design
07/16/2002US6419883 Chemical synthesis using solvent microdroplets
07/11/2002WO2002030354A3 Uridine therapy for patients with elevated purine levels
07/11/2002WO2001040799A3 Method of identifying partial adenosine a1 receptor agonists and their use in the treatment of arrhythmias
07/11/2002WO2001005837A9 Method for assaying compounds affecting smooth muscle contractile state
07/11/2002WO2000061816A9 Electronically mediated nucleic acid amplification in nasba
07/11/2002WO2000053812A3 Replica amplification of nucleic acid arrays
07/11/2002US20020091099 Orally active a1 adenosine receptor agonists
07/11/2002US20020090616 Electrophretic probes for detection and monitoring ligand binding activity
07/10/2002EP1220863A1 Purine derivatives
07/10/2002EP1220862A1 Purine derivatives
07/10/2002CN1358192A 嘌呤衍生物 Purine derivatives
07/10/2002CN1358191A N-pyrazole A2A receptor agonists
07/10/2002CN1358190A Propargyl phenyl ether A2A receptor agonists
07/10/2002CN1358189A C-2A pyrazole A2A receptor agonists
07/09/2002US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC
07/09/2002US6416952 Photolithographic and other means for manufacturing arrays
07/09/2002US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion
07/09/2002US6416949 Composition comprising first solid support linked to peptide covalently attached via linking group to second solid support linked to oligonucleotide, wherein supports are beads covalently attached by heterobifunctional crosslinking agent
07/04/2002WO2002051425A1 Remedies for hepatitis c
07/04/2002WO2002015904B1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
07/04/2002US20020086998 Nucleophile-induced intramolecular ring closure of the C-branched carbohydrate; higher overall yield
07/04/2002US20020086850 Antiinflammatory agents
07/04/2002CA2437209A1 Remedies for hepatitis c
07/03/2002EP1218542A2 Methods and compositions for linear isothermal amplification of polynucleotide sequences
07/03/2002EP1218391A1 Compounds for protecting hydroxyls and methods for their use
07/03/2002EP1169329A4 Oligonucleotides having alkylphosphonate linkages and methods for their preparation
07/03/2002EP0689610B1 Dna sequencing by mass spectrometry via exonuclease degradation
07/03/2002CN1357002A Compositions for treating inflammatory response
07/03/2002CN1086940C Dinucleotides useful for treating lung disease
07/02/2002US6414137 Washing with polar impurity-soluble solvent and non-polar impurity-soluble solvent
07/02/2002US6414135 Phosphonylation of alkylnucleoside with bis(trimethylsilyl)phosphonite in base presence; concentration; adding methanol solvent; nuclease resistance; hybridization
07/02/2002US6414127 Pyrimidine derivatives for labeled binding partners
07/02/2002US6413938 Herpes virus
07/02/2002CA2030875C Methods and probes for detecting nucleoside transporter and method for producing the probes